142 related articles for article (PubMed ID: 27523101)
1. Brain tumors in Li-Fraumeni syndrome: a commentary and a case of a gliosarcoma patient.
Guidi M; Giunti L; Lucchesi M; Scoccianti S; Giglio S; Favre C; Oliveri G; Sardi I
Future Oncol; 2017 Jan; 13(1):9-12. PubMed ID: 27523101
[No Abstract] [Full Text] [Related]
2. EGFR-mutated lung cancer in Li-Fraumeni syndrome.
Michalarea V; Calcasola M; Cane P; Tobal K; Izatt L; Spicer J
Lung Cancer; 2014 Sep; 85(3):485-7. PubMed ID: 25047674
[TBL] [Abstract][Full Text] [Related]
3. High frequency of de novo mutations in Li-Fraumeni syndrome.
Gonzalez KD; Buzin CH; Noltner KA; Gu D; Li W; Malkin D; Sommer SS
J Med Genet; 2009 Oct; 46(10):689-93. PubMed ID: 19556618
[TBL] [Abstract][Full Text] [Related]
4. Rare IDH1 variants are common in pediatric hemispheric diffuse astrocytomas and frequently associated with Li-Fraumeni syndrome.
Sumerauer D; Krskova L; Vicha A; Misove A; Mamatjan Y; Jencova P; Vlckova M; Slamova L; Vanova K; Liby P; Taborsky J; Koblizek M; Klubal R; Kyncl M; Zadeh G; Stary J; Zamecnik J; Ramaswamy V; Zapotocky M
Acta Neuropathol; 2020 Apr; 139(4):795-797. PubMed ID: 31897644
[No Abstract] [Full Text] [Related]
5. Li-Fraumeni and Li-Fraumeni-like syndrome among children diagnosed with pediatric cancer in Southern Brazil.
Giacomazzi J; Selistre SG; Rossi C; Alemar B; Santos-Silva P; Pereira FS; Netto CB; Cossio SL; Roth DE; Brunetto AL; Zagonel-Oliveira M; Martel-Planche G; Goldim JR; Hainaut P; Camey SA; Ashton-Prolla P
Cancer; 2013 Dec; 119(24):4341-9. PubMed ID: 24122735
[TBL] [Abstract][Full Text] [Related]
6. Li-Fraumeni syndrome presenting as cutaneous melanoma in a child: case report and review of literature.
Baek YS; Seo JY; Song JY; Lee SY; Kim A; Jeon J
J Eur Acad Dermatol Venereol; 2019 Apr; 33(4):e174-e175. PubMed ID: 30653764
[No Abstract] [Full Text] [Related]
7. Primary Cutaneous Leiomyosarcoma Arising in a Patient With Li-Fraumeni Syndrome: A Neoplasm With Unusual Histopathologic Features and Loss of Heterozygosity at TP53 Gene.
Sabater-Marco V; Ferrando-Roca F; Morera-Faet A; García-García JA; Bosch SB; López-Guerrero JA
Am J Dermatopathol; 2018 Mar; 40(3):225-227. PubMed ID: 28475508
[No Abstract] [Full Text] [Related]
8. Germline TP53 mutations and Li-Fraumeni syndrome.
Varley JM
Hum Mutat; 2003 Mar; 21(3):313-20. PubMed ID: 12619118
[TBL] [Abstract][Full Text] [Related]
9. Acute myelogenous leukemia in a patient with Li-Fraumeni syndrome treated with valproic acid, theophyllamine and all-trans retinoic acid: a case report.
Anensen N; Skavland J; Stapnes C; Ryningen A; Børresen-Dale AL; Gjertsen BT; Bruserud Ø
Leukemia; 2006 Apr; 20(4):734-6. PubMed ID: 16437140
[No Abstract] [Full Text] [Related]
10. TP53 germline mutation may affect response to anticancer treatments: analysis of an intensively treated Li-Fraumeni family.
Kappel S; Janschek E; Wolf B; Rudas M; Teleky B; Jakesz R; Kandioler D
Breast Cancer Res Treat; 2015 Jun; 151(3):671-8. PubMed ID: 25981898
[TBL] [Abstract][Full Text] [Related]
11. Malignant triton tumor in a patient with Li-Fraumeni syndrome and a novel TP53 mutation.
Chao MM; Levine JE; Ruiz RE; Kohlmann WK; Bower MA; Petty EM; Mody RJ
Pediatr Blood Cancer; 2007 Dec; 49(7):1000-4. PubMed ID: 16333835
[TBL] [Abstract][Full Text] [Related]
12. Li-Fraumeni and related syndromes: correlation between tumor type, family structure, and TP53 genotype.
Olivier M; Goldgar DE; Sodha N; Ohgaki H; Kleihues P; Hainaut P; Eeles RA
Cancer Res; 2003 Oct; 63(20):6643-50. PubMed ID: 14583457
[TBL] [Abstract][Full Text] [Related]
13. Atypical molecular background of glioblastoma and meningioma developed in a patient with Li-Fraumeni syndrome.
Rieske P; Zakrzewska M; Biernat W; Bartkowiak J; Zimmermann A; Liberski PP
J Neurooncol; 2005 Jan; 71(1):27-30. PubMed ID: 15719270
[TBL] [Abstract][Full Text] [Related]
14. Li-Fraumeni syndrome in a Turkish family.
Karakas Z; Tugcu D; Unuvar A; Atay D; Akcay A; Gedik H; Kayserili H; Dogan O; Anak S; Devecioglu O
Pediatr Hematol Oncol; 2010 May; 27(4):297-305. PubMed ID: 20426520
[TBL] [Abstract][Full Text] [Related]
15. Choroid plexus tumors; management, outcome, and association with the Li-Fraumeni syndrome: the Children's Hospital Los Angeles (CHLA) experience, 1991-2010.
Gozali AE; Britt B; Shane L; Gonzalez I; Gilles F; McComb JG; Krieger MD; Lavey RS; Shlien A; Villablanca JG; Erdreich-Epstein A; Dhall G; Jubran R; Tabori U; Malkin D; Finlay JL
Pediatr Blood Cancer; 2012 Jun; 58(6):905-9. PubMed ID: 21990040
[TBL] [Abstract][Full Text] [Related]
16. Potential of Advexin: a p53 gene-replacement therapy in Li-Fraumeni syndrome.
Nemunaitis JM; Nemunaitis J
Future Oncol; 2008 Dec; 4(6):759-68. PubMed ID: 19086841
[TBL] [Abstract][Full Text] [Related]
17. Association of germline or somatic TP53 missense mutation with oncogene amplification in tumors developed in patients with Li-Fraumeni or Li-Fraumeni-like syndrome.
Sugawara W; Arai Y; Kasai F; Fujiwara Y; Haruta M; Hosaka R; Nishida K; Kurosumi M; Kobayashi Y; Akagi K; Kaneko Y
Genes Chromosomes Cancer; 2011 Jul; 50(7):535-45. PubMed ID: 21484931
[TBL] [Abstract][Full Text] [Related]
18. Successful Treatment of Recurrent Li-Fraumeni Syndrome-related Choroid Plexus Carcinoma.
McEvoy M; Robison N; Manley P; Yock T; Konopka K; Brown RE; Wolff J; Green AL
J Pediatr Hematol Oncol; 2017 Nov; 39(8):e473-e475. PubMed ID: 28859040
[TBL] [Abstract][Full Text] [Related]
19. Identification of a novel TP53 germline mutation in a large Italian Li-Fraumeni syndrome Family.
Capra V; Consales A; Nozza P; Monti P; Inga A; Fronza G
Pediatr Blood Cancer; 2009 Feb; 52(2):303-4. PubMed ID: 18937320
[No Abstract] [Full Text] [Related]
20. The TP53 mutation, R337H, is associated with Li-Fraumeni and Li-Fraumeni-like syndromes in Brazilian families.
Achatz MI; Olivier M; Le Calvez F; Martel-Planche G; Lopes A; Rossi BM; Ashton-Prolla P; Giugliani R; Palmero EI; Vargas FR; Da Rocha JC; Vettore AL; Hainaut P
Cancer Lett; 2007 Jan; 245(1-2):96-102. PubMed ID: 16494995
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
